Sanofi to set up insulin facility in Telangana

HYDERABAD: French vaccine manufacturer Sanofi, though its Indian entity Shantha Biotechnics, will set up an insulin production facility in Telangana, involving an investment of Rs 460 crore.

Sanofi proposes to manufacture Insuman, one of its leading human insulin product for diabetes treatment, at the facility coming in Medak district of Telangana, the second such plant after one at Frankfurt in Germany.

Telangana chief minister K. Chandrasekhar Rao on Thursday laid the foundation stone for the facility, which will have a capacity to produce 60 million cartridges a year.